ADXN Reports Q1 2026 Results
Addex Therapeutics reports Q1 2026 results with operating loss of 0.5 million Swiss francs and cash on hand of 0.9 million
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Addex Therapeutics reports Q1 2026 results with operating loss of 0.5 million Swiss francs and cash on hand of 0.9 million